Musa Tariq is Director at Guardant Health, Inc. (GH). They have made 21 open-market trades across 1 company since 2024, most recently 2026-09-16.
CIK 0001968281
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GH | 11,449 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GH | SELL | 2026-09-16 | 2026-09-17 | $175.00 | $20K | -2.6% | — | — |
| GH | SELL | 2026-08-17 | 2026-08-18 | $156.45 | $18K | -2.2% | +10.7% | — |
| GH | SELL | 2026-07-16 | 2026-07-16 | $163.29 | $19K | -5.8% | +6.1% | +7.0% |
| GH | SELL | 2026-06-22 | 2026-06-23 | $131.16 | $256K | +26.8% | +12.8% | +30.6% |
| GH | SELL | 2026-06-16 | 2026-06-16 | $130.19 | $15K | +20.8% | +21.8% | +31.8% |
| GH | SELL | 2026-05-18 | 2026-05-19 | $95.96 | $11K | +28.5% | +31.1% | +60.8% |
| GH | SELL | 2026-04-16 | 2026-04-16 | $84.83 | $10K | -4.1% | +10.4% | +88.0% |
| GH | SELL | 2026-03-18 | 2026-03-19 | $88.09 | $31K | +4.1% | +2.6% | +45.5% |
| GH | SELL | 2025-12-17 | 2025-12-18 | $101.46 | $12K | +5.7% | +18.9% | -9.7% |
| GH | SELL | 2025-11-19 | 2025-11-20 | $96.25 | $11K | +6.2% | +1.6% | +7.7% |
| GH | SELL | 2025-10-17 | 2025-10-20 | $66.95 | $8K | +31.8% | +42.0% | +63.8% |
| GH | SELL | 2025-09-17 | 2025-09-17 | $55.63 | $6K | +8.4% | +14.5% | +74.9% |
| GH | SELL | 2025-08-19 | 2025-08-20 | $59.02 | $7K | +14.4% | +1.8% | +64.4% |
| GH | SELL | 2025-07-17 | 2025-07-18 | $48.20 | $6K | -3.4% | +27.1% | +44.2% |
| GH | SELL | 2025-06-18 | 2025-06-20 | $49.47 | $318K | +3.4% | -5.9% | +21.2% |
| GH | SELL | 2025-05-19 | 2025-05-20 | $40.04 | $5K | +7.3% | +25.2% | +51.6% |
| GH | SELL | 2025-04-17 | 2025-04-18 | $44.79 | $5K | +6.6% | -9.2% | +6.7% |
| GH | SELL | 2025-03-19 | 2025-03-20 | $43.70 | $5K | -3.3% | -3.0% | +15.1% |
| GH | SELL | 2025-02-20 | 2025-02-21 | $48.33 | $6K | -1.3% | +8.1% | -14.3% |
| GH | SELL | 2025-01-17 | 2025-01-21 | $37.58 | $4K | +4.1% | +5.0% | -5.6% |
| GH | SELL | 2024-12-18 | 2024-12-19 | $34.85 | $4K | +3.5% | +47.1% | +50.7% |
| GH | SELL · 10b5-1 | 2024-12-13 | 2024-12-16 | $35.00 | $81K | -13.2% | +7.0% | +22.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.